PerkinElmer’s new ACULED VHL and ACULED DYO give customers flexibility to “Design Your Own” Ultra High Power LED for a host of lighting applications
Fremont, CA — May 3, 2007 – PerkinElmer Optoelectronics, a global technology leader in specialty lighting, optical detection technologies, and digital imaging, today announced the availability of the ACULED VHLTM (Very High Lumen) and ACULED DYOTM (Design Your Own), the newest additions to its growing ACULED family of standard and custom LED solutions. The products are debuting at Lightfair International 2007, May 8-10 in New York City.
The new ACULED VHL is offered standard in monochromatic (UV, Blue, Green, Yellow, Red, IR) as well in an RGBY (red-green-blue-yellow) version. With a luminous flux of up to 325 lumens, the ACULED VHL offers outstanding brightness, improved luminous efficacy and all the benefits of the newly enhanced ACULED platform including its compact, easy-to-assemble design; long lifetime and improved thermal management. The thermal resistance of the ACULED VHL package can be as low as 4.5 K/W, depending on the chip configuration. In addition, each chip features a separate anode and cathode, enabling the chips to be driven individually, thus increasing flexibility around electrical layout.
“Customers have been responding very favorably to PerkinElmer’s ACULED RGB product and we are delighted now to be expanding our ACULED offerings,” according to Dr. Michael Kramer, Managing Director LED Solutions, PerkinElmer Optoelectronics.
“In addition to our new standard offerings in the VHL line, our new ACULED DYO gives customers the capability to design their own LED solution based on the next-generation ACULED platform. We believe that the new DYO is the most flexible multi-chip LED available on the market today and affords multiple design options for our customers’ limitless ideas,” Dr. Kramer adds.
The ACULED DYO gives customers the total flexibility to design their own four-chip LED configuration to suit their specific lighting application needs. With the DYO, the menu of options that customers can select from includes visible and non-visible LED chips, sensors, and ESD protection chips.
The ACULED product family enjoys a host of applications including general illumination, specialty lighting, architectural lighting, automotive lighting, entertainment and mood lighting, display lighting, and medical lighting. All products in the ACULED family are fully RoHS-compliant.
PerkinElmer Optoelectronics is a global technology leader in digital imaging, specialty lighting and optical detection technologies, providing applications-driven, integrated solutions to leading OEMs in Health Sciences and Industrial Sciences markets. More information about PerkinElmer Optoelectronics is available at http://optoelectronics.perkinelmer.com/content/corporate/news/pressreleases.aspx.
Factors Affecting Future Performance
This press release contains “forward-looking” statements within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements relating to estimates and projections of future earnings per share and revenue growth and other financial results, developments relating to our customers and end-markets, and plans concerning business development opportunities. Words such as “believes,” “intends,” “anticipates,” “plans,” “expects,” “projects,” “forecasts,” “will” and similar expressions, and references to guidance, are intended to identify forward-looking statements. Such statements are based on management’s current assumptions and expectations and no assurances can be given that our assumptions or expectations will prove to be correct. A number of important risk factors could cause actual results to differ materially from the results described, implied or projected in any forward-looking statements. These factors include, without limitation: (1) our failure to introduce new products in a timely manner; (2) our ability to execute acquisitions and license technologies, or to successfully integrate acquired businesses and licensed technologies into our existing business or to make them profitable; (3) our failure to protect adequately our intellectual property; (4) the loss of any of our licenses or licensed rights; (5) our ability to compete effectively; (6) fluctuation in our quarterly operating results and our ability to adjust our operations to address unexpected changes; (7) our ability to produce an adequate quantity of products to meet our customers’ demands; (8) our failure to maintain compliance with applicable government regulations; (9) regulatory changes; (10) economic, political and other risks associated with foreign operations; (11) our ability to retain key personnel; (12) restrictions in our credit agreement; (13) our ability to realize the full value of our intangible assets; and (14) other factors which we describe under the caption “Risk Factors” in our most recent annual report on Form 10-K and in our most recent quarterly report on Form 10-Q and in our other filings with the Securities and Exchange Commission. We disclaim any intention or obligation to update any forward-looking statements as a result of developments occurring after the date of this press release.
Health Sciences end markets include genetic screening, environmental, service, biopharma, and medical imaging. Photonics markets include sensors and specialty lighting.